IOL Chemicals and Pharmaceuticals Limited (IOLCP.NS)
INR 434.5
(7.04%)
INR 434.5
(7.04%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 21.32 Billion | 22.17 Billion | 21.68 Billion | 19.46 Billion | 18.63 Billion | 16.55 Billion |
| Cost of Revenue | 16.6 Billion | 15.47 Billion | 15.96 Billion | 11.24 Billion | 10.84 Billion | 10.66 Billion |
| Gross Profit | 4.71 Billion | 6.7 Billion | 5.71 Billion | 8.21 Billion | 7.78 Billion | 5.88 Billion |
| Operating Expenses | 2.2 Billion | 4.9 Billion | 3.55 Billion | 2.68 Billion | 2.4 Billion | 2.1 Billion |
| Selling, General and Administrative Expenses | 2.02 Billion | 676.8 Million | 713.4 Million | 548.3 Million | 508.9 Million | 480.7 Million |
| Research and Development Expenses | 173.7 Million | 167.5 Million | 111.4 Million | 74.7 Million | 67.6 Million | 58.7 Million |
| Other Expenses | - | 256.1 Million | 33.1 Million | 12.7 Million | 14.8 Million | 7.4 Million |
| Cost and Expenses | 16.38 Billion | 20.37 Billion | 19.52 Billion | 13.93 Billion | 13.25 Billion | 12.77 Billion |
| Operating Income | 4.94 Billion | 1.8 Billion | 2.16 Billion | 5.53 Billion | 5.38 Billion | 3.77 Billion |
| Interest Expense | 108.4 Million | 164.7 Million | 24.3 Million | 9.4 Million | 160.1 Million | 466.5 Million |
| Income Tax Expense | 472.2 Million | 495.1 Million | 571.8 Million | 1.26 Billion | 1.71 Billion | 994.5 Million |
| Earnings before Tax | 1.81 Billion | 1.88 Billion | 2.24 Billion | 5.71 Billion | 5.33 Billion | 3.36 Billion |
| Net Income | 1.34 Billion | 1.39 Billion | 1.67 Billion | 4.44 Billion | 3.61 Billion | 2.36 Billion |
| Earnings Per Share Basic | 22.90 | 23.70 | 28.56 | 76.21 | 63.51 | 42.11 |
| Earnings Per Share Diluted | 22.90 | 23.70 | 28.56 | 76.21 | 63.38 | 42.11 |
| Weighted Average Shares Outstanding | 58.7 Million | 58.7 Million | 58.7 Million | 58.33 Million | 56.88 Million | 56.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.7 Million | 58.7 Million | 58.7 Million | 58.33 Million | 57 Million | 56.2 Million |
| Gross Margin | 0.22 | 0.30 | 0.26 | 0.42 | 0.42 | 0.36 |
| EBIT Margin | 0.12 | 0.11 | 0.13 | 0.31 | 0.31 | 0.25 |
| Profit Margin | 0.06 | 0.06 | 0.08 | 0.23 | 0.19 | 0.14 |
| EBITDA | 2.6 Billion | 2.51 Billion | 2.76 Billion | 6.16 Billion | 5.89 Billion | 4.2 Billion |
| Earnings Before Tax Margin | 0.23 | 0.08 | 0.10 | 0.28 | 0.29 | 0.23 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 5.02 Billion | 5.03 Billion | 21.32 Billion | 5.2 Billion | 5.45 Billion | 5.63 Billion |
| Cost of Revenue | 4.06 Billion | 3.88 Billion | 16.6 Billion | 3.55 Billion | 3.53 Billion | 3.64 Billion |
| Gross Profit | 961.4 Million | 1.15 Billion | 4.71 Billion | 1.64 Billion | 1.91 Billion | 1.98 Billion |
| Operating Expenses | 618.5 Million | 822.3 Million | 3.04 Billion | 1.36 Billion | 1.43 Billion | 1.4 Billion |
| Selling, General and Administrative Expenses | 618.5 Million | 822.3 Million | - | 718 Million | 785.9 Million | 540.9 Million |
| Research and Development Expenses | - | 173.7 Million | - | 86.85 Million | - | - |
| Other Expenses | 73.8 Million | 75.2 Million | 300.7 Million | 83.8 Million | 71.1 Million | 70.6 Million |
| Cost and Expenses | 4.68 Billion | 4.7 Billion | 19.65 Billion | 4.92 Billion | 4.96 Billion | 5.05 Billion |
| Operating Income | 342.9 Million | 330.9 Million | 1.67 Billion | 363.9 Million | 556.2 Million | 580.7 Million |
| Interest Expense | 21.5 Million | 34.1 Million | 161 Million | 43 Million | 44.4 Million | 39.5 Million |
| Income Tax Expense | 95.5 Million | 95.8 Million | 472.2 Million | 90.1 Million | 133.1 Million | 153.2 Million |
| Earnings before Tax | 395.2 Million | 372 Million | 1.81 Billion | 320.9 Million | 511.8 Million | 611.8 Million |
| Net Income | 299.7 Million | 276.2 Million | 1.34 Billion | 230.8 Million | 378.7 Million | 458.6 Million |
| Earnings Per Share Basic | 5.11 | 4.71 | - | 3.93 | 6.45 | 7.81 |
| Earnings Per Share Diluted | 5.11 | 4.71 | - | 3.93 | 6.45 | 7.81 |
| Weighted Average Shares Outstanding | 58.7 Million | 58.7 Million | 58.7 Million | 58.7 Million | 58.7 Million | 58.7 Million |
| Weighted Average Shares Outstanding (Diluted) | 58.7 Million | 58.7 Million | 58.7 Million | 58.7 Million | 58.7 Million | 58.7 Million |
| Gross Margin | 0.19 | 0.23 | 0.22 | 0.32 | 0.35 | 0.35 |
| EBIT Margin | 0.10 | 0.10 | - | 0.10 | 0.13 | 0.14 |
| Profit Margin | 0.06 | 0.05 | 0.06 | 0.04 | 0.07 | 0.08 |
| EBITDA | 511.1 Million | 495.2 Million | - | 527.3 Million | 713.1 Million | 795.8 Million |
| Earnings Before Tax Margin | 0.07 | 0.07 | 0.08 | 0.07 | 0.10 | 0.10 |
3531
WELINV
BUTTERFLY
2939
4100
INDIANHUME